September 27th, 2016 1:11 pm
High Risk: The Debate Over the Price of Specialty Drugs and Zika Virus
In an interview with CFIF, Dr. Scott Gottlieb, Resident Fellow at the American Enterprise Institute, discusses the history and regulations surrounding drug prices, who should finance important medical advancements, and the continuing Zika threat.
Listen to the interview here.
CFIF Freedom Line Blog RSS Feed
CFIF on Twitter
CFIF on YouTube